Echo IQ is trading 10.09% higher at A$0.60, with no confirmed catalyst for the rise. - ASX’s announcement list has no company update dated September 30, 2026; its latest listed update was the September 17 EchoSolv HF FDA application update. - Supplied market context shows no significant index move to explain the gain, pointing to an isolated share-price move rather than a confirmed broader-market or company-specific driver.